Skip to main content

EXMINT 7.2 Successfully Completed

Published

25.03.2025

Category

The EXMINT 7.2 course has been successfully completed, marking another important milestone in the European Stroke Course in Minimally Invasive Neurological Therapy (EXMINT) series.

Exmint 7 2 Group

Five Days of Intensive Learning

Over 80 participants attended this five-day on-site course at the Orea Hotel Pyramida in Prague. The course provided in-depth theoretical training on ischemic stroke treatment, complemented by hands-on sessions.

Exmint 7 2 Lecture

The program covered a wide range of topics, including:

  • Guideline updates and recent developments in stroke treatment
  • Recanalization strategies for intracranial and extracranial occlusions
  • Managing complications such as intracranial hematoma and futile recanalization
  • Advanced techniques like robotic mechanical thrombectomy and intracranial stenting

Participants engaged in multiple lectures, led by Prof. AntonĂ­n Krajina (Course Director) and Prof. Wim van Zwam (Chair EXMINT Committee). The faculty included 14 experts from across Europe, offering lectures, tutorials, and interactive discussions.

Looking Ahead

With both EXMINT X.1. and EXMINT X.2 completed, participants are eligible to take the European Diploma in Ischaemic Stroke Intervention (EDSI) exam, scheduled for Friday, 2 May 2025.

Registration for the exam is open. The deadline for registration is 12 noon CEST on Friday, 4 April 2025. Successful candidates will receive their diploma at the ESMINT Congress in September.

About EXMINT

EXMINT is a specialized course designed to provide physicians with intensive training in the neurointerventional treatment of ischemic stroke. It consists of two parts: a virtual theoretical course (EXMINT X.1) and an in-person theoretical course (EXMINT X.2), with additional hands-on training. Graduates of the program can pursue certification through the European Diploma in Ischaemic Stroke Intervention (EDSI).

We congratulate all participants of EXMINT 7.2 on their successful completion and look forward to their next steps in neurointerventional stroke treatment!